{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=25560&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=25520&ordering=-accession","results":[{"accession":"CLO:0017468","name":"GM16688 cell","definition":"[' HUMAN VARIATION PANEL - CHINESE (VERSION 2) CHINESE POPULATION']","term_type":"cell line"},{"accession":"CLO:0017467","name":"GM12491 cell","definition":"[' CEPH/UTAH PEDIGREE 1330']","term_type":"cell line"},{"accession":"CLO:0017466","name":"GM16687 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0017465","name":"GM12490 cell","definition":"[' CEPH/UTAH PEDIGREE 1328']","term_type":"cell line"},{"accession":"CLO:0017464","name":"GM12485 cell","definition":"[' CEPH/UTAH PEDIGREE 1355 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]']","term_type":"cell line"},{"accession":"CLO:0017463","name":"GM12484 cell","definition":"[' CEPH/UTAH PEDIGREE 1357']","term_type":"cell line"},{"accession":"CLO:0017462","name":"GM12487 cell","definition":"[' CEPH/UTAH PEDIGREE 1355']","term_type":"cell line"},{"accession":"CLO:0017461","name":"GM12486 cell","definition":"[' CEPH/UTAH PEDIGREE 1355']","term_type":"cell line"},{"accession":"CLO:0017460","name":"GM16667 cell","definition":"[' ATAXIA-TELANGIECTASIA; AT']","term_type":"cell line"},{"accession":"CLO:0017459","name":"GM16666 cell","definition":"[' ATAXIA-TELANGIECTASIA; AT']","term_type":"cell line"},{"accession":"CLO:0017458","name":"GM16660 cell","definition":"[' RET PROTOONCOGENE; RET MULTIPLE ENDOCRINE NEOPLASIA, TYPE II; MEN2']","term_type":"cell line"},{"accession":"CLO:0017457","name":"GM12483 cell","definition":"[' CEPH/UTAH PEDIGREE 1357']","term_type":"cell line"},{"accession":"CLO:0017456","name":"GM12482 cell","definition":"[' CEPH/UTAH PEDIGREE 1357']","term_type":"cell line"},{"accession":"CLO:0017455","name":"GM16659 cell","definition":"[' MULTIPLE ENDOCRINE NEOPLASIA, TYPE II; MEN2 RET PROTOONCOGENE; RET']","term_type":"cell line"},{"accession":"CLO:0017454","name":"GM16686 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0017453","name":"GM16685 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0017452","name":"GM16684 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC']","term_type":"cell line"},{"accession":"CLO:0017451","name":"GM16678 cell","definition":"[' RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3']","term_type":"cell line"},{"accession":"CLO:0017450","name":"ND01426 cell","definition":"[\" PARKINSON'S DISEASE\"]","term_type":"cell line"},{"accession":"CLO:0017449","name":"ND01429 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"}]}